Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Pharmaceutical Marketplace Q&A with Chris Oostyen

By Pharmaceutical Processing | September 24, 2015

Chris Oostyen from Iwata LabelQ: What do you see as the most significant regulatory requirement currently impacting the pharmaceutical marketplace, and why?
A:
I don’t see any one significant regulatory requirement impacting the pharmaceutical marketplace, as there numerous necessary requirements. I do, however, see a need to standardize regulatory requirements between countries. Each country has its own requirements, and there needs to be an effort with the pharmaceutical marketplace to harmonize drug regulations globally. This will allow needed drugs to get to all markets quickly and with the same quality and safety. 

Q: Which production, packaging, or software technology do you feel could have the most impact on a processors’ business, and why?
A:
I feel that the generic market will have a significant impact the on market over the next several years. With the aging population, the rising cost of drugs and healthcare, and the need for various drugs in highly populated and poor areas of the world, generics will be sought after by larger population of patients. I don’t think this trend will slow down in the immediate future.

Q: A primary focus of Pharma Expo is education. If you could convince pharmaceutical manufacturing companies to invest in one area of employee education, what would it be and why?
A:
Again, I don’t think that there is one specific area of employee education that needs to be focused on. More so, a move to increase the amount of ongoing education, increasing qualifications, and professional development of present employees and health care workers. We all need to keep abreast of new technologies, philosophies and developments in safety standards that protect and provide added service and value to both employees and patients alike. 

Q: Which superhero do you think would be the best fit for the pharmaceutical industry and why?
A:
I would say Superman, because he is an easily and commonly recognized superhero. He is a symbol of honesty, integrity, and service. He protects the citizens of the world, as well as protecting the planet. He provides a feeling of comfort and safety, which is something the pharmaceutical industry needs.

Q: If you could give the pharmaceutical marketplace one thing, what would it be?
A:
The pharmaceutical industry is a very detailed and serious work environment. This attitude is very important to have in order to be able to provide the quality of drugs demanded by the public and also to clear all the regulations imposed on this industry. But sometimes this attitude is a little over the top. It would be great if there was a way to include a little more fun/relaxed type of feeling within the marketplace. All work and no play—you know how that goes.

 

Pharma EXPO Innovation Stage Presentation Details:
Title: Risk in the Workplace – Preventing Shattered Vials and Protecting Handlers of Highly Toxic Drugs
Date: Tue. September 29 | 1:00 PM – 1:30 PM |
Location: Innovation Stage | Booth N-559 Pharma EXPO |
Description: Broken vials, shattered glass, and exposure to contents are every drug handler’s nightmare. The risk to caregivers and others who handle these drugs is quite prevalent. Not to mention costly cleanup and decontamination procedures. In this presentation we will provide a solution for limiting vial breakage and providing content containment.

Related Articles Read More >

Great Point Partners logo.
Great Point Partners acquires majority stake in Eutecma to fuel sustainable cold chain growth
Driving success in fast-paced high-tech pharma construction projects
This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE